4911 資生堂

時価

9880億円

PER 予

164.43倍

2010年以降

赤字-131.57倍
（2010-2024年）

1.61倍

2010年以降

1.31-8.24倍
（2010-2024年）

1.62%

ROE 予

0.98%

ROA 予

0.47%

Research And Development ExpensesSGA、Share Of Other Comprehensive Income Of Investments Accounted For Using Equity Method Net Of Tax Items That May Be Reclassified To Profit Or LossOCIIFRS

【期間】

1Q
3Q
通期
全期間

年度	Research And Development ExpensesSGA		Share Of Other Comprehensive Income Of Investments Accounted For Using Equity Method Net Of Tax Items That May Be Reclassified To Profit Or LossOCIIFRS
2013/03	137億		-
2014/03	135億	-0.9%	-
2015/03	142億	+5.1%	-
2015/12	113億	-20.6%	-
2016/12	183億	+61.6%	-
2017/12	242億	+32.7%	-
2018/12	291億	+20.2%	-
2019/12	317億	+8.8%	-
2020/12	270億	-14.8%	-
2021/12	256億	-5.1%	-
2022/12	246億	-4%	-
2023/12	261億	+5.9%	-
2024/12	254億	-2.5%	-

2013年3月

Research And Development ExpensesSGA: 136億5900万
Share Of Other Comprehensive Income Of Investments Accounted For Using Equity Method Net Of Tax Items That May Be Reclassified To Profit Or LossOCIIFRS: -

2014年3月

Research And Development ExpensesSGA: 135億4000万
Share Of Other Comprehensive Income Of Investments Accounted For Using Equity Method Net Of Tax Items That May Be Reclassified To Profit Or LossOCIIFRS: -

2015年3月

Research And Development ExpensesSGA: 142億2600万
Share Of Other Comprehensive Income Of Investments Accounted For Using Equity Method Net Of Tax Items That May Be Reclassified To Profit Or LossOCIIFRS: -

2015年12月

Research And Development ExpensesSGA: 112億9900万
Share Of Other Comprehensive Income Of Investments Accounted For Using Equity Method Net Of Tax Items That May Be Reclassified To Profit Or LossOCIIFRS: -

2016年12月

Research And Development ExpensesSGA: 182億6400万
Share Of Other Comprehensive Income Of Investments Accounted For Using Equity Method Net Of Tax Items That May Be Reclassified To Profit Or LossOCIIFRS: -

2017年12月

Research And Development ExpensesSGA: 242億3000万
Share Of Other Comprehensive Income Of Investments Accounted For Using Equity Method Net Of Tax Items That May Be Reclassified To Profit Or LossOCIIFRS: -

2018年12月

Research And Development ExpensesSGA: 291億3000万
Share Of Other Comprehensive Income Of Investments Accounted For Using Equity Method Net Of Tax Items That May Be Reclassified To Profit Or LossOCIIFRS: -

2019年12月

Research And Development ExpensesSGA: 316億9700万
Share Of Other Comprehensive Income Of Investments Accounted For Using Equity Method Net Of Tax Items That May Be Reclassified To Profit Or LossOCIIFRS: -

2020年12月

Research And Development ExpensesSGA: 269億9200万
Share Of Other Comprehensive Income Of Investments Accounted For Using Equity Method Net Of Tax Items That May Be Reclassified To Profit Or LossOCIIFRS: -

2021年12月

Research And Development ExpensesSGA: 256億1900万
Share Of Other Comprehensive Income Of Investments Accounted For Using Equity Method Net Of Tax Items That May Be Reclassified To Profit Or LossOCIIFRS: -

2022年12月

Research And Development ExpensesSGA: 245億9100万
Share Of Other Comprehensive Income Of Investments Accounted For Using Equity Method Net Of Tax Items That May Be Reclassified To Profit Or LossOCIIFRS: -

2023年12月

Research And Development ExpensesSGA: 260億5000万
Share Of Other Comprehensive Income Of Investments Accounted For Using Equity Method Net Of Tax Items That May Be Reclassified To Profit Or LossOCIIFRS: -

2024年12月

Research And Development ExpensesSGA: 253億8700万
Share Of Other Comprehensive Income Of Investments Accounted For Using Equity Method Net Of Tax Items That May Be Reclassified To Profit Or LossOCIIFRS: -